Last reviewed · How we verify
Clinical guidelines based therapy
Clinical guidelines based therapy is a Small molecule drug developed by Children's Hospital of Fudan University. It is currently FDA-approved.
Clinical guidelines based therapy refers to treatment protocols developed and implemented according to established clinical practice guidelines rather than a single molecular mechanism.
Clinical guidelines based therapy involves the use of evidence-based interventions such as Cardiac Magnetic Resonance Imaging (CMR) guidance for left ventricular lead implantation, Acceptance and Commitment Therapy for mental health conditions, and Abbott FreeStyle Libre 3 for diabetes management. These interventions have been studied in various conditions including Heart Failure, Type 2 Diabetes, Bronchiolitis, Depression Anxiety Disorder, and Geriatric Diseases, and are grounded in the use of small molecule modality.
At a glance
| Generic name | Clinical guidelines based therapy |
|---|---|
| Sponsor | Children's Hospital of Fudan University |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
This represents a therapeutic approach at Children's Hospital of Fudan University that follows standardized clinical guidelines for patient management. It is not a discrete pharmaceutical agent with a defined molecular target, but rather a systematic treatment protocol or care pathway based on evidence-based clinical guidelines.
Approved indications
Common side effects
Key clinical trials
- "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" (NA)
- Healthy Aging Through Time- Restricted Eating in Adults With Overweight/Obesity and Incipient Liver Disease: ENSATI (NA)
- MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) (PHASE2)
- STRONGER 60+: Assessing the Clinical Effectiveness and Delivery of an Adapted FINGER Model for Brain Health in Primary Care (NA)
- Evaluation of Multiple Interventions to Improve HIV Treatment Outcomes Among People Who Inject Drugs in India (NA)
- Effect of GLP-1 Receptor Agonists on Body Composition in Obesity: The Role of Dietary Protein Consumption in Muscle Mass Maintenance (NA)
- Lung Cancer Prevention Screening Programme in Italy (NA)
- COronoary Microcirculation Analysis NETwork (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Clinical guidelines based therapy CI brief — competitive landscape report
- Clinical guidelines based therapy updates RSS · CI watch RSS
- Children's Hospital of Fudan University portfolio CI
Frequently asked questions about Clinical guidelines based therapy
What is Clinical guidelines based therapy?
How does Clinical guidelines based therapy work?
Who makes Clinical guidelines based therapy?
What development phase is Clinical guidelines based therapy in?
Related
- Manufacturer: Children's Hospital of Fudan University — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing